Effect of Intravitreal Bevacizumab on Focal Edema With Hard Exudates Secondary to Diabetic Retinopathy - Trial NCT01422018
Access comprehensive clinical trial information for NCT01422018 through Pure Global AI's free database. This phase not specified trial is sponsored by Seoul St. Mary's Hospital and is currently status unknown. The study focuses on Diabetes Complications. Target enrollment is 10 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Seoul St. Mary's Hospital
Timeline & Enrollment
N/A
Aug 01, 2011
Feb 01, 2012
Primary Outcome
Changes in best-corrected visual acuity (BCVA)
Summary
Purpose: To evaluate the efficacy of intravitreal bevacizumab (IVB) on focal edema with hard
 exudates secondary to diabetic retinopathy.
 
 Design: Prospective interventional case series. Participants: Ten eyes of 10 consecutive
 patients showing focal edema with hard exudates secondary to diabetic retinopathy which are
 not eligible for focal laser photocoagulation due to central location ( 500 µm from fovea).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT01422018
Non-Device Trial